Dietary resveratrol increases the expression of hepatic 7α-hydroxylase and ameliorates hypercholesterolemia in high-fat fed C57BL/6J mice

Qiong Chen; Ermao Wang; Liping Ma; Pei Zhai
January 2012
Lipids in Health & Disease;2012, Vol. 11 Issue 1, p56
Academic Journal
Background: Resveratrol (RSV), a naturally occurring polyphenolic stilbenoid, is known to possess potent anti-atherogenic properties; however, the effect of RSV on hypercholesterolemia is not fully understood. We hypothesized that RSV decreases blood cholesterol levels through the activation of cholesterol 7α-hydroxylase (CYP7A1)-mediated bile acid synthetic pathway pathways in vitro and in vivo. Methods: In this study, we evaluated body weight, serum lipid concentrations, hepatic lipid content and the size of the bile acid pool in high-fat diet (HFD)-fed C57BL/6 J mice that were treated with RSV. In addition, we characterized the underlying mechanism of the effects of RSV in HepG2 hepatocytes by Western blot analysis. Results: RSV (200 mg/kg per day) reduced body weight and liver weight gains, improved serum lipid parameters, reduced hepatic cholesterol accumulation and increased the bile acid pool size in mice fed an HFD for 8 wks. RSV significantly increased liver expression of CYP7A1 mRNA and protein and CYP7A1 enzyme activity. Furthermore, RSV treatment upregulated CYP7A1 expression and induced liver X receptor alpha (LXRα) activation in a time- and dose-dependent manner in HepG2 cells. In addition, the specific liver X receptor alpha (LXRα) inhibitor geranylgeranyl pyrophosphate (GGPP) inhibited the RSV-induced expression of CYP7A1 in HepG2 hepatocytes. Conclusion: The beneficial effects of RSV on HFD-induced hypercholesterolemia are mediated through LXRα signaling pathways, suggesting a potential target for the prevention of dyslipidemia.


Related Articles

  • Plant sterol ester-enriched milk and yoghurt effectively reduce serum cholesterol in modestly hypercholesterolemic subjects. Noakes, Manny; Clifton, Peter M.; Doornbos, Anne M. E.; Trautwein, Elke A. // European Journal of Nutrition;Jun2005, Vol. 44 Issue 4, p214 

    Background The cholesterol-lowering efficacy of plant sterol esters (PSteE) or stanol esters (PStaE) in regular- and low-fat spreads has been consistently demonstrated, while their effectiveness in a low-fat, aqueous food carrier such as milk and yoghurt is less well established. Aim of the...

  • Effects of Surface-Deacetylated Chitin Nanofibers in an Experimental Model of Hypercholesterolemia. Kazuo Azuma; Tomone Nagae; Takeshi Nagai; Hironori Izawa; Minoru Morimoto; Yusuke Murahata; Tomohiro Osaki; Takeshi Tsuka; Tomohiro Imagawa; Norihiko Ito; Yoshiharu Okamoto; Hiroyuki Saimoto; Shinsuke Ifuku // International Journal of Molecular Sciences;Aug2015, Vol. 16 Issue 8, p17445 

    This study evaluated the effects of oral administration of surface-deacetylated chitin nanofibers (SDACNFs) on hypercholesterolemia using an experimental model. All rats were fed a high cholesterol diet with 1% w/w cholesterol and 0.5% w/w cholic acid for 28 days. Rats were divided equally into...

  • Ezetimibe for Hypercholesterolemia. Morris, Spencer; Tiller, Rob // American Family Physician;10/15/2003, Vol. 68 Issue 8, p1595 

    Presents an update related to ezetimibe, a drug therapy for the treatment of hypercholesterolemia. Mechanism of action; Safety considerations; Tolerability; Effectiveness.

  • Hearing Loss Due to Familial Hypercholesterolemia and Statin Treatment. Oylumlu, Muhammed; Lolan, Faris Mahmode; Ercan, Suleyman; Altunbas, Gokhan; Karatas, Zeynel; Davutoglu, Vedat // European Journal of Cardiovascular Medicine;2013, Vol. 2 Issue 4, p224 

    It has been suggested that high cholesterol levels might have adverse effects on hearing and interestingly statins may have beneficial effects on hearing loss. Herein, we share a dramatic improvement in acute hearing loss by statin administration in a young patient with familial...

  • The dangers of high cholesterol levels are well known--but low levels may also have hidden risks. Greenhalgh, Trisha // Accountancy;Oct95, Vol. 116 Issue 1226, p62 

    Focuses on health risks posed by both high- and low-levels of cholesterol in the body. Diseases resulting from high levels of lipoproteins; Association of cholesterol-lowering treatments with accidental and premeditated violent death; Debate about cholesterol in the medical press.


    Ingested dihydrocholesterol, a constant companion of cholesterol, is atherogenic in rabbits. The atherosrlerosis is different from that seen in cholesterol fed rabbits. The histologic sequence of events in these lesions over a 51-week period is described in some detail. The lesions occurred in...

  • Effects of Low-Dose Atorvastatin and Rosuvastatin on Plasma Lipid Profiles: A Long-Term, Randomized, Open-Label Study in Patients with Primary Hypercholesterolemia. Mazza, Fabio; Stefanutti, Claudia; Di Giacomo, Serafina; Vivenzio, Antonio; Fraone, Nadia; Mazzarella, Bruno; Bucci, Antonello // American Journal of Cardiovascular Drugs;2008, Vol. 8 Issue 4, p265 

    BACKGROUND AND OBJECTIVE: Despite the favorable effects of reduction of low-density lipoprotein-cholesterol (LDL-C) levels in decreasing the risk of coronary heart disease, many patients treated with lipid-lowering HMG-CoA reductase inhibitors (statins) do not achieve goal LDL-C levels. This...

  • SERUM CHOLESTEROL AS A PREDICTOR OF CAPILLAROPATHY. Barrett, R. A.; Cheraskin, E.; Ringsdorf Jr., W. M. // Angiology;Jul/Aug1970, Vol. 21 Issue 7, p462 

    The article presents a report on serum cholesterol as a predictor of capillaropathy. The association of serum cholesterol with large vessel pathosis is well known. An elevated level of circulating cholesterol has long been recognized as a diagnostic indicator of the arterioselerotic process....

  • Brain region-dependent increases in β-amyloid and apolipoprotein E levels in hypercholesterolemic rabbits. Wu, C.-W.; Liao, P.-C.; Lin, C.; Kuo, C.-J.; Chen, S.-T.; Chen, H.-I.; Kuo, Y.-M. // Journal of Neural Transmission;Jun2003, Vol. 110 Issue 6, p641 

    Summary. Recent studies indicate a possible link between serum cholesterol level, β-amyloid (Aβ) peptide concentrations, and the incidence of Alzheimer's disease (AD). In the present report, the effects of dietary cholesterol on Aβ and apolipoprotein E (APOE) levels in several brain...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics